SEC Form 4 · accession 0001209191-19-004605
TETRAPHASE PHARMACEUTICALS INC · TTPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Guy Macdonald
Officer — President and Chief Executive · Director
Period of report
Jan 17, 2019
Accepted (ET)
Jan 18, 2019 · 6:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001373707
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 14, 2018 | A | 2,058 | — | A | 131,064 | D | |
| Common StockF1 | Nov 14, 2018 | A | 3,332 | — | A | 134,396 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F3 | — | Jan 17, 2019 | A | 100,000 | A | — | — | Common Stock | 100,000 | 100,000 | D |
| Restricted Stock UnitsF2,F4 | — | Jan 17, 2019 | A | 300,000 | A | — | — | Common Stock | 300,000 | 300,000 | D |
Explanation of responses
- F1These shares were purchased pursuant to the issuer's 2014 Employee Stock Purchase Plan.
- F2Each restricted stock unit represents a contingent right to receive one share of common stock of Tetraphase Pharmaceuticals, Inc. for no consideration.
- F3These restricted stock units shall be eligible to vest upon achievement of certain performance conditions and, if such conditions are met, shall vest on various dates beginning no earlier than March 1, 2020 and ending no later than March 1, 2022.
- F4The restricted stock units vest in three equal installments on each of January 17, 2020, January 17, 2021 and January 17, 2022.